Option Care Health (NASDAQ:OPCH) Downgraded to Neutral Rating by The Goldman Sachs Group

The Goldman Sachs Group cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a neutral rating in a research report released on Monday, MarketBeat Ratings reports. The brokerage currently has $27.00 target price on the stock.

A number of other brokerages have also recently issued reports on OPCH. JMP Securities increased their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $43.00 to $29.00 in a report on Wednesday, October 30th. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and cut their target price for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Barrington Research lowered their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Finally, Truist Financial cut their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $30.83.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $22.49 on Monday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a one year low of $22.46 and a one year high of $34.63. The firm has a market capitalization of $3.83 billion, a P/E ratio of 18.90, a PEG ratio of 1.90 and a beta of 1.32. The company’s fifty day moving average is $30.31 and its two-hundred day moving average is $29.85.

Insider Activity at Option Care Health

In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.

Hedge Funds Weigh In On Option Care Health

A number of large investors have recently modified their holdings of OPCH. UMB Bank n.a. raised its holdings in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after buying an additional 750 shares during the period. GAMMA Investing LLC raised its stake in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its holdings in shares of Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares in the last quarter. Blue Trust Inc. boosted its position in Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after purchasing an additional 377 shares during the period. Finally, SageView Advisory Group LLC acquired a new stake in Option Care Health in the 1st quarter valued at $85,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.